Clara Locher

4.0k citations

54 papers · 1.7k indexed · h-index 22

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Phagocytosis and Immune Regulation
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research

Papers in

Virology 4
Statistics, Probability and Uncertainty 6
- Meta-analysis and systematic reviews 5

Co-authors: Laurence Zitvogel Guido Kroemer Laetitia Aymeric Oliver Kepp Yuting Ma Takahiro Yamazaki François Ghiringhelli Lionel Apétoh
Journals: Journal of Clinical Oncology (3 papers)Seminars in Immunology (2 papers)Journal of Clinical Epidemiology (2 papers)Annals of Oncology (2 papers)OncoImmunology (2 papers)
Partner nations: France United States Italy

In The Last Decade

Clara Locher

49 papers receiving 1.7k citations

Peers

Countries citing papers authored by Clara Locher

Since Specialization

Citations

This map shows the geographic impact of Clara Locher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Locher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Locher more than expected).

Fields of papers citing papers by Clara Locher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Locher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Locher. The network helps show where Clara Locher may publish in the future.

Co-authors

The 25 scholars most cited alongside Clara Locher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clara Locher Line = papers co-authored together Clara Locher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reusing clinical trial data to consolidate and advance medical knowledge Journal of Clinical Epidemiology ·Giuseppe Varvara, James Askew, Clara Locher, Joseph S. Ross, Ulrich Mansmann, Florian Naudet	2025	0
2	Implementing clinical trial data sharing requires training a new generation of biomedical researchers Nature Medicine ·Ulrich Mansmann, Clara Locher, Fabian Praßer, Tracey L. Weissgerber, Ulrich Sax, Martin Posch, Évelyne Decullier, Ioana A. Cristea, Thomas P. A. Debray, Leonhard Held, David Moher, John P. A. Ioannidis, Joseph S. Ross, Christian Ohmann, Florian Naudet	2023	14
3	The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020 International Journal of Cancer ·Viktoria Gloy, Andreas M. Schmitt, Hualong Liu, Julian Hirt, Cathrine Axfors, Daniely Rocha Insabral, Tiago Pereira, Clara Locher, V. Franco, J Gilbert, Mark P. Lythgoe, Amanda K. Herbrand, Benjamin Kasenda, Lars G. Hemkens	2023	24
4	Replication of systematic reviews: is it to the benefit or detriment of methodological quality? Journal of Clinical Epidemiology ·Céline Chapelle, Édouard Ollier, Moslem Mahdavifar, Clara Locher, Paul Zufferey, Michel Cucherat, Silvy Laporte	2023	2
5	Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature BMC Cancer ·V. Franco, Y. Ahmad, P. Álvarez, Alejandro Téllez Ramírez, Bruno Laviolle, Florian Naudet, Clara Locher	2022	8
6	A survey of biomedical journals to detect editorial bias and nepotistic behavior PLoS Biology ·信寺本, Florian Naudet, Ioana A. Cristea, David Moher, Dorothy Bishop, Clara Locher	2021	21
7	Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases BMJ evidence-based medicine ·Clara Locher, David Moher, Ioana A. Cristea, Florian Naudet	2021	6
8	435P Bevacizumab (bev) continuation with FOLFIRI or switch to aflibercept (afli) with FOLFIRI as second-line treatment (L2) after first line of FOLFOX-bev (L1) for metastatic colorectal cancer (mCRC): An AGEO multicenter study Annals of Oncology ·Sanford Levinson, Simon Pernot, Greta Papadimitriou Cámara, Violaine Randrian, Solène Doat, Mihong Lee, И Б Щербак, Seyed Masoud Lahsaee, Olivier Dubreuil, Anthony Turpin, Мисир Джумаил оглы Марданов, Olivier Bouché, Thierry Lecomte, David Sefrioui, Clara Locher, Cindy Neuzillet, Elise F. Nassif, C. Lécaille, Julien Taı̈eb, Édouard Auclin	2020	0
9	Effect of a Perioperative Nutritional Supplementation with Oral Impact® in Patients undergoing Hepatic Surgery for Liver Cancer: A Prospective, Placebo-Controlled, Randomized, Double-Blind Study Nutrition and Cancer ·Philippe Séguin, Clara Locher, Karim Boudjéma, 龍司一高, Ikra Rahmawati, Yannick Mallédant, Éric Bellissant	2016	20
10	ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8) Annals of Oncology ·Pierre Laurent‐Puig, P. T. Kirstein, Anne Cayre, Karine Le Malicot, Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem, J. Thaler, Lone Nørgård Pétersen, P.J. Myers, John Bridgewater, Stephen B. Ellis, Clara Locher, Christine Lagorce, HERVÉ DE COTTREAU, Côme Lepage, Frédérique Penault‐Llorca, Julien Taı̈eb	2016	37
11	Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity Antioxidants and Redox Signaling ·Sylvain Ladoire, Dalil Hannani, Marie Vétizou, Clara Locher, Laetitia Aymeric, Lionel Apétoh, Oliver Kepp, Guido Kroemer, François Ghiringhelli, Laurence Zitvogel	2013	37
12	Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer British Journal of Cancer ·Nathalie Chaput, Magali Svrcek, A. Aupérin, Clara Locher, Françoise Drusch, David Malka, Julien Taı̈eb, Diane Goèré, Michel Ducreux, Valérie Boige	2013	40
13	Phase I clinical trial combining imatinib mesylate and IL-2 OncoImmunology ·Nathalie Chaput, Caroline Flament, Clara Locher, Mélanie Desbois, Annie Rey, Sylvie Rusakiewicz, Vichnou Poirier-Colame, Patricia Pautier, Axel Le Cesne, Jean‐Charles Soria, Angélo Paci, Michèlle Rosenzwajg, David Klatzmann, Alexander Eggermont, Caroline Robert, Laurence Zitvogel	2013	23
14	Natural killer cells in non-hematopoietic malignancies Frontiers in Immunology ·Mélanie Desbois, Sylvie Rusakiewicz, Clara Locher, Laurence Zitvogel, Nathalie Chaput	2012	22
15	Harnessing dendritic cells in cancer Seminars in Immunology ·Lionel Apétoh, Clara Locher, François Ghiringhelli, Guido Kroemer, Laurence Zitvogel	2011	49
16	Integration of Host-Related Signatures with Cancer Cell–Derived Predictors for the Optimal Management of Anticancer Chemotherapy Cancer Research ·Laurence Zitvogel, Oliver Kepp, Laetitia Aymeric, Yuting Ma, Clara Locher, Nicolas F. Delahaye, Fabrice André, Guido Kroemer	2010	23
17	The dendritic cell–tumor cross-talk in cancer Current Opinion in Immunology ·Yuting Ma, Laetitia Aymeric, Clara Locher, Guido Kroemer, Laurence Zitvogel	2010	61
18	Witch Hunt against Tumor Cells Enhanced by Dendritic Cells Annals of the New York Academy of Sciences ·Clara Locher, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apétoh, Guido Kroemer, Laurence Zitvogel	2009	10
19	Molecular Cloning of the Human Immunodeficiency Virus Subtype 2 Strain HIV-2UC2 Virology ·Susan W. Barnett, Harold Legg, Yan Sun, Xin Yu, David J. Blackbourn, Clara Locher, J A Levy	1996	14
20	Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants Journal of Ethnopharmacology ·Clara Locher, Ditre, Howard F. Mower, John M. Berestecky, Adhila Ukhtina Utami, B. Van Poel, A. Lasure, D. A. Vanden Berghe, A. J. Vlietinck	1995	140

About Clara Locher

Clara Locher is a scholar working on Virology, Statistics, Probability and Uncertainty, Immunology, Hepatology and Pharmacology, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Meta-analysis and systematic reviews (5 papers), Phagocytosis and Immune Regulation (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). The work is most often cited by research in Immunology (729 citations), Oncology (707 citations), Hepatology (162 citations), Physiology (46 citations) and Virology (44 citations). Clara Locher has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Laurence Zitvogel, Guido Kroemer, Laetitia Aymeric, Oliver Kepp, Yuting Ma, Takahiro Yamazaki, François Ghiringhelli, Lionel Apétoh, Sandy Adjemian and Isabelle Martins. Their work appears in journals such as Journal of Clinical Oncology, Seminars in Immunology, Journal of Clinical Epidemiology, Annals of Oncology and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact